SENSEX 77,690.95

-984.23

NIFTY 23,559.05

-324.40

CRUDEOIL 5,809.00

+ 33.00

GOLD 75,070.00

+ 169.00

SILVER 90,021.00

+ 694.00

SENSEX 77,690.95

-984.23

NIFTY 23,559.05

-324.40

NIFTY 23,559.05

-324.40

CRUDEOIL 5,809.00

+ 33.00

CRUDEOIL 5,809.00

+ 33.00

GOLD 75,070.00

+ 169.00

Portfolio

Kesavan A N 1612@Chennai

Market correction broad-based with 7 of 10 stocks of BSE AllCap seeing a fall

FPI outflows overlapping with earnings slowdown and the return of the dragon weigh in

By Arun K Shanmugam

When the taxman comes knocking

Technical Analysis

Movers & Shakers: Stocks that will see action this week

Good time to buy quality index funds

Stock Fundamentals

Why you should home in on this premium realty player

Personal Finance

Ayushman Bharat senior citizen health insurance: Benefits and enrolment details

Mastering Derivatives: Does futures price decay?

Today's Poll

FILE PHOTO: Donald Trump, the US president-elect, attends a campaign rally at Macomb Community College in Warren, Michigan, U.S., November 1, 2024.

Will Trump’s victory augur well for India?

Stock Fundamentals

L&T-E2E deal: AI frenzy or real boom?

IndusInd, Bandhan, RBL, IDFC First, Kotak, Ujjivan et al. - Dissecting the MFI worry

Big Story

REUTERS

Trump, tariffs and tax cuts – Can they power the US stock markets ahead?

Getty Images

IndusInd, Bandhan, RBL, IDFC First, Kotak, Ujjivan et al. - Dissecting the MFI worry

Getty Images/iStockphoto

Where is gold headed and what’s the best way to buy gold this Diwali?

Make hay while the sun shines and wind howls

Nifty 50, Dow Jones, Nifty Auto, Nifty Midcap100, Nifty Pharma: How to use ratio charts to identify the peak and outperformers

SRF, Deepak Nitrite, Gujarat Fluro, Navin Fluorine, et al: Speciality chemicals at a crossroads

Derivatives

F&O Strategy: Short Torrent Pharma

Crude Check: No clarity in trend

Bullion Cues: Rally likely post dip

F&O Tracker: Index futures seek direction

Mastering Derivatives: Does futures price decay?

F&O Query: Should you hold call options on Infosys and Voltas?

F&O Query: Should you hold or exit Federal Bank call option?

Mastering Derivatives: Interpreting put-call ratio

Stock Fundamentals

Niva Bupa Health Insurance IPO: Should you subscribe?

The company’s ability to reign in claims in the next three years is key monitorable

By Sai Prabhakar BL Research Bureau

Why you should home in on this premium realty player

While the performance of other sectors in aggregate is commendable, the weakness in segments such as FMCG, construction materials (steel and cement) and automobiles, point to a slowing demand currently.

Post mixed Q2, India Inc may face tailwinds in second half of FY25

Niva Bupa Health Insurance IPO: Should you subscribe?

L&T-E2E deal: AI frenzy or real boom?

Swiggy IPO analysis: You can take a shot, but maybe not a big swig

What is the outlook for Maruti Suzuki stock after weak Q2FY25 results?

Dhanuka Agritech: What should investors do?

Sign into Unlock benefits!

Access 10 free stories per month
Access to comment on every story
Sign up/Manage to our newsletters
Get notified by email for early preview to new features, discounts & offers